Efavirenz is an FDA-approved antiretroviral medication introduced in 1998 (and approved for use in the UE in 1999) that has played a pivotal role in the treatment and prevention of HIV. As a member of the non-nucleoside reverse transcriptase inhibitor (NNRTI) class, efavirenz is an integral component of antiretroviral therapy (ART) regimens. By selectively inhibiting the reverse transcriptase enzyme, an essential catalyst for transcribing viral RNA into DNA, efavirenz disrupts the replication process of the human immunodeficiency virus. This module discusses the indications, contraindications, mechanism of action, pharmacokinetics, dosing guidelines, adverse effects, and potential drug interactions associated with efavirenz while highlighting its role in combating HIV and providing clinicians with essential insights for optimal patient management.
- Provider:StatPearls, LLC
- Activity Link: https://www.statpearls.com/ArticleLibrary/viewarticle/20920
- Start Date: 2023-09-01 05:00:00
- End Date: 2023-09-01 05:00:00
- Credit Details: IPCE Credits: 1.0 hours
AMA PRA Category 1 Credit™️: 1.0 hours
Nursing: 1.0 hours
Pharmacy: 1.0 hours - MOC Credit Details: ABS - 1.0 Point; Credit Type(s): Accredited CME (ABS)
ABPATH - 1.0 Point; Credit Type(s): Lifelong Learning (ABPATH)
ABA - 1.0 Point; Credit Type(s): Lifelong Learning (ABA)
ABIM - 1.0 Point; Credit Type(s): Medical Knowledge (ABIM)
ABS - 1.0 Point; Credit Type(s): Self-Assessment (ABS)
ABP - 1.0 Point; Credit Type(s): Lifelong Learning and Self-Assessment (ABP) - Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Variable
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
- Specialty: Adolescent Medicine, Ambulatory/Outpatient, Chemical Pathology, General Operative Anesthesia, General Pediatrics, General Surgery, Infectious Disease, Infectious Diseases/Medical Microbiology, Internal Medicine, Neonatal-Perinatal Medicine, Pediatric Infectious Diseases